A WHO report published 4 November 2026 models how six scaled-up climate and health actions could avert 1.6 million deaths each year globally. These are modelled potential benefits, not observed deaths already prevented.
WHO’s 4 November 2026 midterm assessment of its 2021–2030 neglected tropical disease road map documents major gains alongside persistent surveillance and funding gaps.
WHO’s 4 November 2026 global estimates report that about one in four adolescents aged 11–17 had no day with at least 60 minutes of moderate-to-vigorous activity in the preceding week.
On 4 November 2026 WHO announced that expert groups recommended adding two Bundibugyo-virus vaccine candidates to the ongoing Tumaini trial in the Democratic Republic of the Congo, subject to national approvals.
WHO’s Technical Advisory Group on Market Access for Vaccines held its eighth scheduled meeting in Geneva on 4 November 2026; an explainer on vaccine supply, affordability and what has not been announced.
WHO’s 4 November 2026 EPI-WIN launch explains the scope of integrated clinical guidance for dengue, chikungunya, Zika and yellow fever, including outpatient triage and hospital referral.
On 3 November 2026, WHO/Europe convenes a Brussels dialogue with FAO, UNEP and WOAH on governance, surveillance and preparedness under One Health.
WHO’s 2 November 2026 IGWG9 remarks explain the unresolved pathogen access and benefit-sharing annex and why no final agreement should yet be claimed.
WHO’s 1 November 2026 review of 14 studies across nine countries identifies continuity-of-care lessons for ANC, postpartum care, contraception and community health.
WHO confirms World AMR Awareness Week on 18–24 November 2026. Explore the One Health theme, antibiotic stewardship, IPC and a practical CHC action plan.
